@article{article_1767228, title={The effect of liver cirrhosis on early postoperative complications after sleeve gastrectomy: a matched case-control study}, journal={Journal of Medicine and Palliative Care}, volume={6}, pages={507–510}, year={2025}, author={Ocaklı, Serhat and Canlıkarakaya, Fırat and Altunsaray, Ayten and Doğan, İbrahim and Chouseın, Bourak and Karabacak, Harun and Ceylan, Cengiz and Banlı, Oktay}, keywords={siroz, sleeve gastrektomi, komplikasyon, bariatrik cerrahi}, abstract={Aims: Obesity-related liver disease begins with non-alcoholic fatty liver disease (NAFLD) and may progress to non-alcoholic steatohepatitis (NASH) and cirrhosis. Sleeve gastrectomy (SG) is an effective treatment, though some patients only seek it after liver damage has occurred. While cirrhosis increases surgical risk, SG may still be viable for selected child A patients, with potential benefits outweighing the risks, as noted in recent guidelines. This study aims to evaluate the impact of liver cirrhosis on first 30-day postoperative complications following SG. Methods: A 1:3 retrospective matched case-control design was used. Early postoperative complications were assessed using the Clavien-Dindo classification. Seven patients with cirrhosis (cases) and 21 without (controls) were included. Results: The median age was 51 (44-62) in the case group and 51 (44-61) in controls. Median body-mass index (BMI) was 45.7 kg/m2 (39.9-48.4) for cases and 44.7 kg/m2 (40.3-47) for controls, with no significant demographic differences. Excluding the 3-points for cirrhosis, the median Charlson Comorbidity Index (CCI) for other comorbidities was 2 in both groups. In the cirrhotic group, 3 had CDC grade 1 and 1 had grade 2 complications; in the control group, 2 had grade 1 and 1 had grade 2. No severe complications (Clavien-Dindo >IIIa) occurred, and there was no significant difference in minor complications (p <0.05). Conclusion: No early complications were observed that would contraindicate SG in child A cirrhotic patients. These findings may support risk-benefit evaluations in similar cases and guide future prospective studies.}, number={5}, publisher={MediHealth Academy Yayıncılık}